Eric Pasmant Selected Research

Eric Pasmant Research Topics

Disease

28	Neoplasms (Cancer) 01/2023 - 04/2007
7	Plexiform Neurofibroma 10/2022 - 01/2011
7	Carcinogenesis 10/2022 - 12/2012
6	Neurofibrosarcoma (MPNST) 10/2022 - 01/2014
4	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2018 - 11/2011
3	Neurofibroma 10/2022 - 05/2011
3	Melanoma (Melanoma, Malignant) 01/2020 - 04/2007
3	Breast Neoplasms (Breast Cancer) 01/2016 - 04/2007
2	Cholelithiasis 10/2023 - 03/2012
2	Glioma (Gliomas) 09/2023 - 01/2018
2	Hyperplasia 05/2022 - 01/2022
2	Adrenocortical Carcinoma 04/2022 - 01/2018
2	Endometrial Neoplasms (Endometrial Cancer) 01/2020 - 01/2019
2	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2019 - 01/2018
2	Neurofibromatoses (Neurofibromatosis) 01/2018 - 01/2010
2	Schwannomatosis 01/2018 - 01/2018
1	Adenocarcinoma of Lung 02/2024
1	Gilbert Disease 10/2023
1	Hyperbilirubinemia 10/2023
1	Mesenchymal Chondrosarcoma 01/2023
1	Chondrosarcoma 01/2023
1	Thyroid Neoplasms (Thyroid Cancer) 01/2022
1	Oncogene Addiction 01/2022
1	Disease Progression 01/2022
1	Cushing Syndrome 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Water Intoxication 12/2021
1	type 1 familial Hypocalciuric hypercalcemia 12/2021
1	Hypercalcemia (Milk Alkali Syndrome) 12/2021
1	Hyperparathyroidism 12/2021
1	Infections 01/2021
1	COVID-19 01/2021
1	Adenoma (Adenomas) 01/2020
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2020
1	Adenocarcinoma 12/2019
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 10/2018
1	Sarcoma (Soft Tissue Sarcoma) 10/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2010
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2011
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2023 - 12/2007
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2018
3	Tumor Suppressor Protein p14ARF (p14ARF)IBA 08/2019 - 04/2007
3	ChromatinIBA 01/2019 - 12/2015
3	MicroRNAs (MicroRNA)IBA 06/2016 - 01/2011
2	ParaffinIBA 04/2022 - 01/2020
2	Exonucleases (3' 5' Exonuclease)IBA 01/2022 - 01/2019
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2020
2	EnzymesIBA 01/2021 - 01/2019
2	VemurafenibIBA 01/2020 - 01/2017
2	LigandsIBA 01/2020 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 06/2016 - 03/2012
2	RNA (Ribonucleic Acid)IBA 01/2016 - 01/2016
2	Untranslated RNA (Noncoding RNA)IBA 11/2011 - 04/2007
1	Immune Checkpoint InhibitorsIBA 02/2024
1	BilirubinIBA 10/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2022
1	larotrectinibIBA 01/2022
1	IodineIBA 01/2022
1	trametinibIBA 01/2022
1	gastric inhibitory polypeptide receptorIBA 01/2022
1	NivolumabIBA 01/2022
1	Diphosphonates (Bisphosphonates)IBA 12/2021
1	Calcium-Sensing ReceptorsIBA 12/2021
1	CalciumIBA 12/2021
1	remdesivirIBA 01/2021
1	VaccinesIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Nonsense Codon (Nonsense Mutation)IBA 07/2020
1	ProteomeIBA 01/2020
1	N 30IBA 01/2020
1	theasinensin AIBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2020
1	Secretin FDA Link 12/2019
1	Colloids (Colloid)IBA 12/2019
1	Adenosine Monophosphate (AMP)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2019
1	Neurofibromin 2 (Merlin)IBA 01/2019
1	TubulinIBA 01/2019
1	Polycomb Repressive Complex 2IBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 10/2018
1	AntigensIBA 01/2018
1	Circulating Tumor DNAIBA 01/2018
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2018
1	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	ElementsIBA 01/2018
1	Neurofibromin 1 (Neurofibromin)IBA 01/2018

Therapy/Procedure

9	Therapeutics 01/2022 - 12/2012
2	Drug Therapy (Chemotherapy) 01/2023 - 10/2018
2	Radiotherapy 01/2023 - 01/2020
2	Immunotherapy 01/2022 - 01/2020
2	Genomic Medicine 01/2020 - 10/2018
1	Adjuvant Chemotherapy 01/2020